Compass Therapeutics (CMPX) Enterprise Value Growth (1y) (2019 - 2026)
Compass Therapeutics (CMPX) Enterprise Value Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Compass Therapeutics | 388.64 Mn | 193.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -72.85% |
| Dec 31, 2025 | -64.56% |
| Sep 30, 2025 | -86.34% |
| Jun 30, 2025 | 30.96% |
| Mar 31, 2025 | 28.06% |
| Dec 31, 2024 | 16.51% |
| Sep 30, 2024 | 27.92% |
| Jun 30, 2024 | 13.35% |
| Mar 31, 2024 | 10.62% |
| Dec 31, 2023 | 18.28% |
| Sep 30, 2023 | -35.74% |
| Jun 30, 2023 | -27.82% |
| Mar 31, 2023 | -28.44% |
| Dec 31, 2022 | -29.10% |
| Sep 30, 2022 | -372.78% |
| Mar 31, 2022 | -243.57% |
| Dec 31, 2021 | -206.98% |
| Sep 30, 2021 | 54.05% |
| Mar 31, 2021 | -1,059,846.60% |
| Dec 31, 2020 | -86.05% |